Search Results

There are 1228 results for: content related to: A Return to Normal Erectile Function with Tadalafil Once Daily after an Incomplete Response to As-Needed PDE 5 Inhibitor Therapy

  1. You have full text access to this OnlineOpen article
    Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study

    International Journal of Clinical Practice

    Volume 68, Issue 9, September 2014, Pages: 1087–1099, J. Buvat, D. Hatzichristou, F. G. Boess, H. Büttner, N. Gehchan, C. Henneges and H. Porst

    Version of Record online : 14 AUG 2014, DOI: 10.1111/ijcp.12449

  2. Comparison of Efficacy, Safety, and Tolerability of On-Demand Tadalafil and Daily Dosed Tadalafil for the Treatment of Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 2, Issue 3, May 2005, Pages: 415–427, Chris McMahon

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1743-6109.2005.20360.x

  3. You have free access to this content
    The Treatment of Erectile Dysfunction study: focus on treatment satisfaction of patients and partners

    BJU International

    Volume 99, Issue 2, February 2007, Pages: 376–382, Gerald Brock, John Chan, 1 Serge Carrier, 2 Melanie Chan, 1 Luis Salgado, 3 Alexander H. Klein, 4 Clement Lang, 5 Richard Horner, 6 Stephen Gutkin and 7 Ruth Dickson 1

    Version of Record online : 28 NOV 2006, DOI: 10.1111/j.1464-410X.2006.06586.x

  4. You have free access to this content
    Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ observational study

    BJU International


    Version of Record online : 2 AUG 2006, DOI: 10.1111/j.1464-410X.2006.06384.x

  5. Effect of Tadalafil on Cytochrome P450 3A4–mediated Clearance: Studies in Vitro and in Vivo

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 1, January 2005, Pages: 63–75, Barbara J. Ring, Beverley E. Patterson, Malcolm I. Mitchell, Mark Vandenbranden, Jennifer Gillespie, Alun W. Bedding, Hayley Jewell, Christopher D. Payne, S. Thomas Forgue, James Eckstein, Steven A. Wrighton and Diane L. Phillips

    Version of Record online : 16 JAN 2005, DOI: 10.1016/j.clpt.2004.09.006

  6. Tadalafil inclusion in microporous silica as effective dissolution enhancer: Optimization of loading procedure and molecular state characterization

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 5, May 2011, Pages: 1805–1818, Mohammed M. Mehanna, Adel M. Motawaa and Magda W. Samaha

    Version of Record online : 22 DEC 2010, DOI: 10.1002/jps.22420

  7. Tadalafil Enhances the Inhibitory Effects of Tamsulosin on Neurogenic Contractions of Human Prostate and Bladder Neck

    The Journal of Sexual Medicine

    Volume 9, Issue 9, September 2012, Pages: 2293–2306, Javier Angulo, Pedro Cuevas, Argentina Fernández, José M. La Fuente, Antonio Allona, Ignacio Moncada and Iñigo Sáenz de Tejada

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1743-6109.2012.02821.x

  8. Safety, Efficacy, and Pharmacokinetic Overview of Low-Dose Daily Administration of Tadalafil

    The Journal of Sexual Medicine

    Volume 6, Issue 7, July 2009, Pages: 2039–2048, Rebecca Wrishko, Sebastian Sorsaburu, David Wong, Andrew Strawbridge and James McGill

    Version of Record online : 28 APR 2009, DOI: 10.1111/j.1743-6109.2009.01301.x

  9. A Randomized Open-Label Trial with a Crossover Comparison of Sexual Self-Confidence and Other Treatment Outcomes Following Tadalafil Once a Day Vs. Tadalafil or Sildenafil On-Demand in Men with Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 9, Issue 5, May 2012, Pages: 1418–1429, Eusebio Rubio-Aurioles, Hartmut Porst, Edward D. Kim, Francesco Montorsi, Geoff Hackett, Antonio Martin Morales, Bronwyn Stuckey, Hartwig Būttner, Teena M. West, Ngan N. Huynh, Enrique Lenero, Patrick Burns and Vladimir Kopernicky

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1743-6109.2012.02667.x

  10. The Clinical Pharmacokinetics of Phosphodiesterase-5 Inhibitors for Erectile Dysfunction

    The Journal of Clinical Pharmacology

    Volume 45, Issue 9, September 2005, Pages: 987–1003, Dr Manish Gupta, Dr Andreas Kovar and Dr Bernd Meibohm

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005276847

  11. ORIGINAL RESEARCH—PHARMACOTHERAPY FOR ED: Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction Previously Unresponsive to On-demand Tadalafil

    The Journal of Sexual Medicine

    Volume 1, Issue 3, November 2004, Pages: 292–300, Chris McMahon

    Version of Record online : 13 OCT 2004, DOI: 10.1111/j.1743-6109.04042.x

  12. You have free access to this content
    An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy

    BJU International

    Volume 96, Issue 9, December 2005, Pages: 1323–1332, Ian Eardley, Vincenzo Mirone, Francesco Montorsi, David Ralph, Philip Kell, Margaret R. Warner, Yanli Zhao and Anthony Beardsworth

    Version of Record online : 15 NOV 2005, DOI: 10.1111/j.1464-410X.2005.05892.x

  13. Efficacy and Safety of Oral Tadalafil in the Treatment of Men in Canada with Erectile Dysfunction: A Randomized, Double-Blind, Parallel, Placebo-Controlled Clinical Trial

    The Journal of Sexual Medicine

    Volume 2, Issue 5, September 2005, Pages: 685–698, Serge Carrier, Gerald B. Brock, Peter J. Pommerville, Janey Shin, Greg Anglin, Steven Whitaker and Charles M. Beasley Jr

    Version of Record online : 6 JUL 2005, DOI: 10.1111/j.1743-6109.2005.00097.x

  14. No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 12, December 2009, Pages: 4962–4974, Rebecca Spence, Arun Mandagere, Brooke Harrison, Christopher Dufton and Ramesh Boinpally

    Version of Record online : 19 MAY 2009, DOI: 10.1002/jps.21789

  15. Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 6, June 2013, Pages: 639–649, Matthew A. Cantrell, Jordan Baye and Scott Martin Vouri

    Version of Record online : 25 MAR 2013, DOI: 10.1002/phar.1243

  16. You have free access to this content
    Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men

    International Journal of Urology

    Volume 20, Issue 2, February 2013, Pages: 193–201, Osamu Yokoyama, Masaki Yoshida, Sae Chul Kim, Chii-Jye Wang, Takeshi Imaoka, Yoji Morisaki and Lars Viktrup

    Version of Record online : 7 SEP 2012, DOI: 10.1111/j.1442-2042.2012.03130.x

  17. Tadalafil Effect on Metabolic Syndrome-Associated Bladder Alterations: An Experimental Study in a Rabbit Model

    The Journal of Sexual Medicine

    Volume 11, Issue 5, May 2014, Pages: 1159–1172, Linda Vignozzi, Sandra Filippi, Paolo Comeglio, Ilaria Cellai, Annamaria Morelli, Elena Maneschi, Erica Sarchielli, Mauro Gacci, Marco Carini, Gabriella Barbara Vannelli and Mario Maggi

    Version of Record online : 26 FEB 2014, DOI: 10.1111/jsm.12478

  18. Timing of Dose Relative to Sexual Intercourse Attempt in Previous Sildenafil Citrate Users Treated with Tadalafil

    The Journal of Sexual Medicine

    Volume 3, Issue 2, March 2006, Pages: 309–319, Sidney Glina, Mariano Sotomayor, Eduardo Gatchalian, Onder Yaman, Yulia Dyachkova, Caroline Markey and Vladimir Kopernicky

    Version of Record online : 20 FEB 2006, DOI: 10.1111/j.1743-6109.2006.00220.x

  19. You have free access to this content
    The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease

    British Journal of Clinical Pharmacology

    Volume 60, Issue 5, November 2005, Pages: 459–468, Dean Patterson, Robert Kloner, Mark Effron, Jeffrey Emmick, Alun Bedding, Margaret Warner, Malcolm Mitchell, Simon Braat and Thomas MacDonald

    Version of Record online : 1 AUG 2005, DOI: 10.1111/j.1365-2125.2005.02479.x

  20. Update on Clinical Trials of Tadalafil Demonstrates No Increased Risk of Cardiovascular Adverse Events

    The Journal of Sexual Medicine

    Volume 1, Issue 2, September 2004, Pages: 161–167, Graham Jackson, Robert A. Kloner, Timothy M. Costigan, Margaret R. Warner and Jeffrey T. Emmick

    Version of Record online : 13 SEP 2004, DOI: 10.1111/j.1743-6109.2004.04024.x